This inventor holds 3 USPTO granted patents. Top assignees: Incyte Corporation, Incyte Genomics, Inc., Incyte Pharmaceuticals, Inc.. Active years: 1999-2005.
Company Filing History:
1 out of 686 
1 out of 163 
1 out of 576 
Years Active: 1999-2005
Title: Douglas H Gooding: Innovator in Cyclic GMP Phosphodiesterase
Introduction
Douglas H Gooding is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of cyclic GMP phosphodiesterase, holding a total of 3 patents. His work has implications for treating various disorders associated with this enzyme.
Latest Patents
One of his latest patents focuses on human cyclic GMP phosphodiesterase (PDE9A). This invention provides polynucleotides that identify and encode PDE9A. Additionally, it includes expression vectors, host cells, antibodies, agonists, and antagonists. The invention also outlines methods for treating or preventing disorders linked to the expression of PDE9A.
Career Highlights
Throughout his career, Douglas H Gooding has worked with prominent companies such as Incyte Genomics, Inc. and Incyte Pharmaceuticals, Inc. His expertise in the field has allowed him to contribute to significant advancements in biotechnology.
Collaborations
Some of his notable coworkers include Douglas A Fisher and David Gray Streeter. Their collaborative efforts have furthered research and development in their respective fields.
Conclusion
Douglas H Gooding's innovative work in cyclic GMP phosphodiesterase has paved the way for potential treatments of related disorders. His contributions to biotechnology continue to impact the industry positively.